Published in:
01-01-2019
CT colonography screening in extracolonic cancer survivors: impact on rates of colorectal and extracolonic findings by cancer type
Published in: Abdominal Radiology | Issue 1/2019
Login to get accessAbstract
Purpose
To compare the rates of colorectal and extracolonic findings at CT colonography (CTC) screening between patients with and without a personal prior history of other.
Methods
Over a 160-month interval, 349 adults (mean age, 60.3 years; 67% female) with a positive history of extracolonic cancer [Ca(+)], excluding 271 patients with isolated non-melanoma skin cancers, underwent CTC screening. This study cohort was compared against 8859 controls (mean age, 57.0 years; 53% female) without a prior cancer history [Ca(−)]. Primary outcome measures included the rates of relevant colorectal (C-RADS C2–C4) and extracolonic (C-RADS E3-E4) findings at CTC. Wilcoxon rank sum test was used to test for statistical significance with post-hoc analysis by relative rate (RR).
Results
Both colorectal (C2–C4) and extracolonic (E3–E4) findings were significantly increased in the Ca(+) group versus Ca(−) control group (p = 0.0283 and 0.0236, respectively). Positive colorectal findings were most notably increased among survivors of non-small cell lung cancer (RR 3.1), head/neck cancers (RR, 3.4), and bladder cancers (RR 2.2). The proportion of C2–C4 patients undergoing intervention in the Ca(+) cohort was not significantly different than the Ca(−). Potentially relevant extracolonic findings (E3) were increased in survivors of hematogenous malignancies (RR 2.0), while likely important extracolonic findings (E4) were increased in survivors of female gynecological malignancies (RR 3.4).
Conclusions
Relevant colorectal and extracolonic findings at CTC screening are increased in patients with a previous extracolonic cancer history, particularly among certain cancer subsets. These results may have important implications for choice of colorectal test in these patients.